Turkey, coronavirus vaccination

Delta variant already accounts for 90% of coronavirus infections in Turkey

In the last 24 hours, Turkey registered a rebound in infections, with 19,918 positives and 204 deaths from COVID-19.

More than 90% of the new coronavirus infections in Turkey are already caused by the so-called Delta variant, the strain that emerged in India, as announced yesterday by the Turkish Minister of Health, Fahrettin Koca, who also pointed out that the cases of the Delta plus strain– also emerged in India, and more contagious and virulent – are not many, but are spreading rapidly.

“These variants show a high rate of infectivity among the population,” Koca warned journalists after a government cabinet meeting in which new measures against the pandemic were approved, including the obligation for those who reject the coronavirus vaccine to undergo PCR tests, especially in sectors such as education, where face-to-face classes are expected to resume in early September.

Despite these data, and that in the last 24 hours there was a rebound in infections with 19,918 positives and 204 deaths from COVID-19, Koca ruled out a new confinement and attributed the increase in positivity to greater mobility due to the end of the restrictions and the lack of compliance with security measures against the pandemic, such as the use of mask or social distance, especially in closed spaces.

Regarding the vaccination campaign, the Minister of Health assured that Turkey does not have a vaccine supply problem and hoped that more and more reluctant people decide to get vaccinated; Koca further explained that those who have received two doses of the Chinese Sinovac vaccine – the first supplied in Turkey – will need to receive a third dose.

“This is because its effectiveness decreases after 3 to 6 months after the second dose. For the Pfizer-BioNTech vaccine, a third dose is not necessary, although we know that it decreases its protection after 7-8 months ”, especially against infections by the Delta variant of the coronavirus. “Right now a third dose of the Pfizer-BioNTech vaccine is not necessary, but we will inform the public if necessary,” he concluded.